(Q38177169)

24407450

30 August 2017

title

Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects (English)

1 reference

30 August 2017

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24407450%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Nelson Durán

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24407450%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

5

Stefania Galdiero

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24407450%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Massimiliano Galdiero

6

object named as

Massimiliano Galdiero

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24407450%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Kateryna Kon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24407450%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Avinash Ingle

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24407450%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

language of work or name

English

0 references

publication date

10 January 2014

1 reference

24407450

Applied Microbiology and Biotechnology

30 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24407450%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24407450%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24407450%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

1951-1961

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24407450%20AND%20SRC:MED&resulttype=core&format=json

Current status on marine products with reversal effect on cancer multidrug resistance

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Antimicrobial effects of TiO(2) and Ag(2)O nanoparticles against drug-resistant bacteria and leishmania parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Antileishmanial effect of silver nanoparticles and their enhanced antiparasitic activity under ultraviolet light

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Heightened reactive oxygen species generation in the antimicrobial activity of a three component iodinated chitosan-silver nanoparticle composite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Fabrication of silver nanoparticles by Phoma glomerata and its combined effect against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Noble metal nanoparticles applications in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Enhanced antimicrobial activity of silver nanoparticles synthesized by Cryphonectria sp. evaluated singly and in combination with antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Biogenic silver for disinfection of water contaminated with viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Silver nanoparticles: a brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Antimicrobial and synergistic effects of silver nanoparticles synthesized using soil fungi of high altitudes of eastern himalaya

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Insecticide resistance in head lice: clinical, parasitological and genetic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Interaction of silver nanoparticles with HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

The effects of silver dressings on chronic and burns wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Fungus-mediated synthesis of silver nanoparticles and their activity against pathogenic fungi in combination with fluconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Silver nanoparticles as potential antiviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Emerging virus diseases: can we ever expect the unexpected?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Synthesis of silver nanoparticles using Piper longum leaf extracts and its cytotoxic activity against Hep-2 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Fungal mediated biosynthesis of silver nanoparticles, characterization and antimicrobial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Efficacy of plant-mediated synthesized silver nanoparticles against hematophagous parasites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

An investigation on the cytotoxicity and caspase-mediated apoptotic effect of biologically synthesized silver nanoparticles using Podophyllum hexandrum on human cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Biogenic silver nanoparticles for cancer treatment: an experimental report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

The biological control of the malaria vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Drivers, dynamics, and control of emerging vector-borne zoonotic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Antifungal activity and mode of action of silver nano-particles on Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Mode of antiviral action of silver nanoparticles against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Use of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Antibacterial properties of silver nanoparticles in three different sizes and their nanocomposites with a new waterborne polyurethane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Modes of action of Leishmanicidal antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Biological responses of silver-coated thermosets: an in vitro and in vivo study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Cancer nanotechnology: application of nanotechnology in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Susceptibility of Leishmania to oxygen intermediates and killing by normal macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Synthesis of silver nanoparticles using leaves of Catharanthus roseus Linn. G. Don and their antiplasmodial activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Malaria vector control: from past to future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Role of nanotechnology in agriculture with special reference to management of insect pests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Silver nanoparticles as a new generation of antimicrobials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Active silver nanoparticles for wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Validity of silver, chitosan, and curcumin nanoparticles as anti-Giardia agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Larvicidal potential of silver nanoparticles synthesized using fungus Cochliobolus lunatus against Aedes aegypti (Linnaeus, 1762) and Anopheles stephensi Liston (Diptera; Culicidae).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

From nanotechnology to nanomedicine: applications to cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Investigation of antibacterial properties silver nanoparticles prepared via green method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Interaction of silver nanoparticles with Tacaribe virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Studies on the impact of biosynthesized silver nanoparticles (AgNPs) in relation to malaria and filariasis vector control against Anopheles stephensi Liston and Culex quinquefasciatus Say (Diptera: Culicidae).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Silver nanoparticles inhibit vaccinia virus infection by preventing viral entry through a macropinocytosis-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

In vitro antifungal activity of silver nanoparticles against ocular pathogenic filamentous fungi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

The effect of natural water conditions on the anti-bacterial performance and stability of silver nanoparticles capped with different polymers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Dual antibacterial agents of nano-silver and 12-methacryloyloxydodecylpyridinium bromide in dental adhesive to inhibit caries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Potential use of silver nanoparticles on pathogenic bacteria, their toxicity and possible mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Cancer Therapy Based on Nanomaterials and Nanocarrier Systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5473-X

Methicillin-resistant Staphylococcus aureus: the European landscape

21 January 2018

1 reference

12 December 2020

Topical effectiveness of different concentrations of nanosilver solution on Leishmania major lesions in Balb/c mice

1 reference

12 December 2020

Silver nanoparticles inhibit hepatitis B virus replication.

1 reference

12 December 2020

Rapid green synthesis of silver nanoparticles from silver nitrate by a homeopathic mother tincture Phytolacca Decandra

1 reference

12 December 2020

Advances in the field of nanooncology

1 reference

12 December 2020

Antitumor activity of silver nanoparticles in Dalton's lymphoma ascites tumor model

1 reference

12 December 2020

Acaricidal efficacy of synthesized silver nanoparticles using aqueous leaf extract of Ocimum canum against Hyalomma anatolicum anatolicum and Hyalomma marginatum isaaci (Acari: Ixodidae)

1 reference

12 December 2020

Editorial: Leishmania survival mechanisms: the role of host phosphatases

1 reference

12 December 2020

Antifungal Activity of Silver Ions and Nanoparticles on Phytopathogenic Fungi

1 reference

12 December 2020

Effects of ozone, chlorine dioxide, chlorine, and monochloramine on Cryptosporidium parvum oocyst viability

1 reference

12 December 2020

Antifungal effect of silver nanoparticles on dermatophytes.

1 reference

12 December 2020

Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3.

1 reference

12 December 2020

Update of the drug resistance mutations in HIV-1: March 2013.

1 reference

12 December 2020

Toxicity Study of Silver Nanoparticles Synthesized from Suaeda monoica on Hep-2 Cell Line

1 reference

12 December 2020

Inactivation of microbial infectiousness by silver nanoparticles-coated condom: a new approach to inhibit HIV- and HSV-transmitted infection

1 reference

12 December 2020

A Preliminary Assessment of Silver Nanoparticle Inhibition of Monkeypox Virus Plaque Formation.

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1007/S11671-008-9128-2

Identifiers

DOI

10.1007/S00253-013-5473-X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24407450%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

31 May 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24407450%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

24407450

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24407450%20AND%20SRC:MED&resulttype=core&format=json